ADVFN US – Market Content Editor
-

Entera Bio Names Former Pfizer Executive Geno Germano as Board Chair
Entera Bio Ltd. (NASDAQ:ENTX) has appointed seasoned pharmaceutical executive Geno J. Germano as Chairman of the Board, effective February 4, 2026, as the company approaches several key clinical milestones. He succeeds Gerald Lieberman, who is stepping down from the role. The leadership change comes as Entera prepares to move two oral parathyroid hormone (PTH) peptide…
-

Mint Signs MoU With Rice Robotics to Develop Physical AI Solutions in Asia
Mint Incorporation Limited (NASDAQ:MIMI) said it has signed a non-binding memorandum of understanding through its wholly owned subsidiary, Aspiration X Limited, to explore a strategic joint venture with Rice Robotics Holdings Limited. The proposed venture would focus on advancing localized robotics technology and expanding research and development capabilities in Hong Kong. Under the terms outlined…
-

OLB Group Forms Global Partnership With PayPal to Expand SecurePay Capabilities
The OLB Group, Inc. (NASDAQ:OLB) has entered into a global partnership agreement with PayPal to enhance its SecurePay payment gateway and broaden digital payment options for small and mid-sized businesses. Under the deal, OLB is authorized to integrate and support PayPal’s suite of payment solutions across its merchant network. The move is designed to streamline…
-

Lunai Bioworks Kicks Off AI-Driven Oncology Pilot to Analyze Phase 2 Colorectal Cancer Trial
Lunai Bioworks (NASDAQ: LNAI) has launched a new oncology collaboration with a clinical-stage partner to apply artificial intelligence to data from a randomized Phase 2 trial in metastatic colorectal cancer. The initiative aims to identify biologically relevant patient subgroups that could derive the greatest benefit from the investigational therapy. As part of the pilot agreement,…
-

WEBUY GLOBAL Debuts AI-Powered Premium Travel Brand “Altitude,” Generates About $400K in Initial Bookings
WEBUY GLOBAL LTD. (NASDAQ:WBUY) has unveiled Altitude, a new premium travel advisory concept powered by artificial intelligence, marking a strategic push into higher-value, experience-driven travel. The brand officially launched with a grand opening on January 26, 2026. Shortly after its debut, Altitude recorded roughly $400,000 in confirmed travel bookings, signaling strong early traction for the…
-

Advanced Biomed to Implement 1-for-20 Reverse Stock Split to Meet Nasdaq Requirement
Advanced Biomed Inc. (NASDAQ:ADVB) said it will carry out a 1-for-20 reverse stock split of its issued and outstanding common shares, effective at the opening of trading on The Nasdaq Stock Market on February 20, 2026. The move follows written consent approval on January 12, 2026, by holders of a majority of the company’s voting…
-

Mister Car Wash to Be Taken Private in Leonard Green Deal
Mister Car Wash, Inc. (NASDAQ:MCW) has agreed to a take-private transaction led by affiliates of Leonard Green & Partners, with minority shareholders set to receive $7.00 in cash per share. Under the merger agreement, investors other than the sponsor group will be cashed out at $7.00 per share. The acquisition will be financed in part…
-

Global-e Delivers Record 2025 Performance, Signals Faster Growth in 2026
Global-e Online Ltd. (NASDAQ:GLBE) reported record financial results for 2025 on February 18, 2026, highlighted by strong fourth-quarter momentum and an upgraded growth outlook for the year ahead. In the fourth quarter, gross merchandise value (GMV) rose 37.8% year over year to $2.36 billion, while revenue increased 28% to $336.7 million. Adjusted EBITDA climbed 53%…
-

Spruce Biosciences Reports Positive FDA Meetings as It Prepares TA-ERT Filing for Rare Pediatric Disorder
Spruce Biosciences, Inc. (NASDAQ:SPRB) said it has completed two Type B meetings with the U.S. Food and Drug Administration (FDA), clearing key regulatory discussions ahead of its planned biologics license application (BLA) submission for tralesinidase alfa enzyme replacement therapy (TA-ERT), its experimental treatment for Sanfilippo Syndrome Type B (MPS IIIB). The company met with the…
-

Auddia to Combine With Thramann Holdings, Create McCarthy Finney
Auddia Inc. (NASDAQ:AUUD) said Wednesday that its board has approved a definitive merger agreement with privately held Thramann Holdings, LLC, advancing plans first outlined in a letter of intent signed in August 2025. The proposed deal will reorganize Auddia into a new holding company named McCarthy Finney, which is expected to trade under the ticker…